Stockreport

Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units

Cosmos Holdings Inc.  (COSM) 
NASDAQ:AMEX Investor Relations: cosmosholdingsinc.com/financials
PDF CHICAGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare [Read more]